Iofina becomes founding member of the WIA

RNS Number : 3574C
Iofina PLC
15 October 2015
 

 

15 October 2015

 

Iofina plc

("Iofina" or the "Company")

(LSE AIM: IOF)

 

Iofina becomes founding member of the World Iodine Association

 

Iofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, is pleased to announce it has become a founding member of the World Iodine Association ("WIA"), launched on 14 October 2015 to promote iodine uses and to help eradicate global iodine deficiency.

 

The mission of the WIA is to support and represent iodine producers, processors, formulators, distributors and end-users in relevant industry and official government bodies around the world, with respect to guidelines and regulations on iodine and its derivatives. Alongside Iofina, other founding members of the WIA includes Ajay Europe, Calibre Chemicals, GE Healthcare, Hypred SAS and SQM Europe.

 

The WIA develops, supports and promotes the use of iodine and its derivatives in existing and novel uses and applications in the domains of human and animal health and industry. The WIA provides information about the purposes, uses and applications of iodine and its derivatives to interested parties and aims to help eradicate global iodine deficiency.

 

More information on the WIA can be found at www.worldiodineassociation.com.

 

Commenting on today's landmark news, CEO & President Tom Becker said:

 

"Becoming a founding member of the WIA, alongside a series of prestigious names within our industry, is an important step for a company like Iofina which remains on track to become the second largest producer of Iodine in North America. The formation of the WIA is a highly positive step towards the promotion of iodine and the impact that will have in numerous applications including both animal and human health and nutrition."

 

 

 

For further information, please contact:                                                                                             

 

Dr. Tom Becker, CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

 

Christopher Raggett/Giles Rolls/Joanna Scott

finnCap Ltd

Tel: +44 (0)20 7220 0500

 

Rob Collins/Emily Morris

GMP Securities

Tel: +44 (0)20 7647 2800

 

Dominic Barretto/Harriet Jackson

Yellow Jersey PR Limited

Tel: +44 (0)7768 537 739

 

About Iofina:

 

Iofina specializes in the exploration and production of iodine, iodine specialty chemical derivatives and produced water. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb® technology. Iofina has production operations in the United States, specifically in Montana, Kentucky and Oklahoma. It has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end-products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes. Iofina utilizes its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

www.iofina.com 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAUVOBRVWARARA

Companies

Iofina (IOF)
UK 100

Latest directors dealings